With the analysis of the increased expression of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) evidenced in snRNA-seq data, an increased amount was observed in the fraction of PPARγ+P2RY12+ cells in Alzheimer’s disease patients. Here, PPARG is linked to Alzheimer disease.